SKI Market

A+| A| A-|

Indian Indices

Sensex

75,527.95 1,695.40
( 2.30%)

Global Indices

Nasdaq

51,233.54 363.79
(0.72%)

Dow Jones

7,453.14 37.84
(0.51%)

Hang Seng

66,063.56 1,846.29
(2.88%)

Nikkei 225

10,460.24 156.36
(1.52%)

Forex

USD-INR

95.49 0.16
(0.17%)

EUR-INR

110.25 0.17
(0.15%)

GBP-INR

127.74 0.15
(0.12%)

JPY-INR

0.60 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Balaxi Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532597

INE618N01022

24.0912014

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BALAXI

24.57

126.15

EPS(TTM)

Face Value()

Div & Yield %

0.93

Back

sharanam infraproject & trading ltd

Kuantum Papers standalone net profit declines 53.38% in the December 2025 quarter

Feb 07,2026

Net profit of Kuantum Papers declined 53.38% to Rs 9.78 crore in the quarter ended December 2025 as against Rs 20.98 crore during the previous quarter ended December 2024. Sales rose 7.09% to Rs 287.69 crore in the quarter ended December 2025 as against Rs 268.65 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	287.69	268.65	7
OPM %	13.64	18.76	-
PBDT	29.96	41.97	-29
PBT	13.34	28.16	-53
NP	9.78	20.98	-53

75,527.95 1,695.40 ( 2.30%)

51,233.54 363.79 (0.72%)

7,453.14 37.84 (0.51%)

66,063.56 1,846.29 (2.88%)

10,460.24 156.36 (1.52%)

95.49 0.16 (0.17%)

110.25 0.17 (0.15%)

127.74 0.15 (0.12%)

0.60 0.00 (0.21%)